Mind Historical Cash Flow

MNMD Stock  USD 6.78  0.14  2.02%   
Analysis of Mind Medicine cash flow over time is an excellent tool to project Mind Medicine future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 0.0 or Total Cash From Financing Activities of 265.9 M as it is a great indicator of Mind Medicine ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Mind Medicine latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Mind Medicine is a good buy for the upcoming year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mind Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Mind Stock refer to our How to Trade Mind Stock guide.

About Mind Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Mind balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Mind's non-liquid assets can be easily converted into cash.

Mind Medicine Cash Flow Chart

At present, Mind Medicine's Total Cash From Financing Activities is projected to increase significantly based on the last few years of reporting. The current year's End Period Cash Flow is expected to grow to about 287.4 M, whereas Change In Working Capital is projected to grow to (3.2 M).

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Most accounts from Mind Medicine's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Mind Medicine current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mind Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Mind Stock refer to our How to Trade Mind Stock guide.At present, Mind Medicine's Total Cash From Financing Activities is projected to increase significantly based on the last few years of reporting. The current year's End Period Cash Flow is expected to grow to about 287.4 M, whereas Change In Working Capital is projected to grow to (3.2 M).
 2022 2023 2024 2025 (projected)
Issuance Of Capital Stock42.3M5.7M250.0M262.5M
Stock Based Compensation13.7M15.5M16.9M15.4M

Mind Medicine cash flow statement Correlations

0.520.110.69-0.810.71-0.770.690.3-0.95-0.40.37-0.3-0.260.590.690.23-0.50.5
0.52-0.54-0.04-0.660.86-0.680.340.75-0.54-0.420.02-0.38-0.870.530.330.94-0.50.5
0.11-0.540.250.04-0.380.15-0.03-0.11-0.030.260.230.250.51-0.230.11-0.630.26-0.26
0.69-0.040.25-0.670.44-0.650.87-0.02-0.77-0.560.3-0.340.050.670.64-0.23-0.590.59
-0.81-0.660.04-0.67-0.920.98-0.89-0.680.90.74-0.210.530.62-0.89-0.7-0.520.81-0.81
0.710.86-0.380.44-0.92-0.950.770.73-0.82-0.760.03-0.62-0.810.870.520.76-0.830.83
-0.77-0.680.15-0.650.98-0.95-0.91-0.690.90.84-0.040.670.67-0.95-0.57-0.550.9-0.9
0.690.34-0.030.87-0.890.77-0.910.41-0.85-0.870.05-0.66-0.380.950.570.21-0.90.9
0.30.75-0.11-0.02-0.680.73-0.690.41-0.4-0.56-0.16-0.49-0.840.60.210.8-0.60.59
-0.95-0.54-0.03-0.770.9-0.820.9-0.85-0.40.65-0.190.530.4-0.79-0.63-0.290.72-0.72
-0.4-0.420.26-0.560.74-0.760.84-0.87-0.560.650.410.920.58-0.96-0.15-0.40.99-0.99
0.370.020.230.3-0.210.03-0.040.05-0.16-0.190.410.690.19-0.160.83-0.090.32-0.32
-0.3-0.380.25-0.340.53-0.620.67-0.66-0.490.530.920.690.52-0.810.19-0.350.89-0.89
-0.26-0.870.510.050.62-0.810.67-0.38-0.840.40.580.190.52-0.62-0.17-0.920.63-0.62
0.590.53-0.230.67-0.890.87-0.950.950.6-0.79-0.96-0.16-0.81-0.620.410.46-0.990.99
0.690.330.110.64-0.70.52-0.570.570.21-0.63-0.150.830.19-0.170.410.18-0.250.25
0.230.94-0.63-0.23-0.520.76-0.550.210.8-0.29-0.4-0.09-0.35-0.920.460.18-0.460.45
-0.5-0.50.26-0.590.81-0.830.9-0.9-0.60.720.990.320.890.63-0.99-0.25-0.46-1.0
0.50.5-0.260.59-0.810.83-0.90.90.59-0.72-0.99-0.32-0.89-0.620.990.250.45-1.0
Click cells to compare fundamentals

Mind Medicine Account Relationship Matchups

Mind Medicine cash flow statement Accounts

202020212022202320242025 (projected)
Sale Purchase Of Stock316.8K97.4M98.8M61.0M70.1M48.1M
Change In Cash73.4M53.4M8.6M(42.4M)174.0M182.7M
Change In Working Capital2.1M1.9M(3.8M)6.3M(3.3M)(3.2M)
Depreciation550K2.6M3.2M3.2M527K500.7K
Total Cash From Operating Activities(23.6M)(45.8M)(50.1M)(64.4M)(79.1M)(75.2M)
Net Income(33.9M)(93.0M)(56.8M)(95.7M)(108.7M)(103.2M)
Total Cash From Financing Activities96.7M98.8M59.1M21.8M253.2M265.9M
End Period Cash Flow80.1M133.5M142.1M99.7M273.7M287.4M
Free Cash Flow(23.6M)(45.8M)(50.1M)(64.4M)(79.1M)(75.2M)
Begin Period Cash Flow6.7M80.1M133.5M142.1M99.7M84.8M
Other Cashflows From Financing Activities24.7M16.9M16.8M163K(7.7M)(7.3M)
Other Non Cash Items873K1.2M(6.4M)8.5M15.5M16.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Mind Medicine is a strong investment it is important to analyze Mind Medicine's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mind Medicine's future performance. For an informed investment choice regarding Mind Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mind Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Mind Stock refer to our How to Trade Mind Stock guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mind Medicine. If investors know Mind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.51)
Return On Assets
(0.30)
Return On Equity
(0.68)
The market value of Mind Medicine is measured differently than its book value, which is the value of Mind that is recorded on the company's balance sheet. Investors also form their own opinion of Mind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Mind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mind Medicine's market value can be influenced by many factors that don't directly affect Mind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.